SLU7 Antikörper (AA 301-400) (Cy3)
Kurzübersicht für SLU7 Antikörper (AA 301-400) (Cy3) (ABIN1416305)
Target
Alle SLU7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 301-400
-
Homologie
- Human,Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human SLU7
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- SLU7 (SLU7 Splicing Factor Homolog (SLU7))
-
Andere Bezeichnung
- SLU7
-
Substanzklasse
- Influenza Protein
-
Hintergrund
-
Synonyms: 9G8, hSlu7, MGC9280, Pre mRNA splicing factor SLU7, Pre-mRNA-splicing factor slu7, SLU 7, SLU-7, slu7, SLU7 splicing factor homolog S. cerevisiae, SLU7 splicing factor homolog, SLU7_HUMAN, Step II splicing factor SLU7, Zinc knuckle mot containing.
Background: Participates in the second catalytic step of pre-mRNA splicing, when the free hydroxyl group of exon I attacks the 3'-splice site to generate spliced mRNA and the excised lariat intron. Required for holding exon 1 properly in the spliceosome and for correct AG identification when more than one possible AG exists in 3'-splicing site region. May be involved in the activation of proximal AG. Probably also involved in alternative splicing regulation.
-
Gen-ID
- 10569
-
Pathways
- Ribonucleoprotein Complex Subunit Organization, SARS-CoV-2 Protein Interaktom
Target
-